SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: Graham Marshman who wrote (3206)8/19/1998 2:50:00 PM
From: celeryroot.com  Read Replies (2) | Respond to of 4028
 
And what abt the IND??
I was told by Gibson they were not in pre clinicals
also, the average time to market is 8 years and average cost 400 mil



To: Graham Marshman who wrote (3206)8/20/1998 11:02:00 PM
From: Mr. Forthright  Read Replies (1) | Respond to of 4028
 
Pre-clinical studies? Are those the type that are the beginning of a process which on average will take up to 12 years to get FDA approval and on average cost $359 million? That is a lot of money. Do you think Mike has the credibility to raise that much?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News